The case for prioritizing malignant hematology services in low- and middle-income countries.
Global health
HIV
leukemia
low- and middle-income countries
lymphoma
oncogenic viruses
Journal
Seminars in hematology
ISSN: 1532-8686
Titre abrégé: Semin Hematol
Pays: United States
ID NLM: 0404514
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
28
08
2023
accepted:
31
08
2023
medline:
17
11
2023
pubmed:
19
9
2023
entrez:
18
9
2023
Statut:
ppublish
Résumé
A clear case for can be made for prioritizing malignant hematology services in low- and middle-income countries based on large public health burden, convincing demonstrations of cure and control, innovation opportunities with likely worldwide implications, and sizable returns on investment for health systems and societies. We must now ensure that need and opportunity are matched by commensurate levels of investment and attention.
Identifiants
pubmed: 37723025
pii: S0037-1963(23)00070-7
doi: 10.1053/j.seminhematol.2023.08.005
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
189-191Informations de copyright
Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.